Target Price | $15.20 |
Price | $1.35 |
Potential |
1,025.93%
register free of charge
|
Number of Estimates | 5 |
5 Analysts have issued a price target Reviva Pharmaceuticals Holdings Inc. 2025 .
The average Reviva Pharmaceuticals Holdings Inc. target price is $15.20.
This is
1,025.93%
register free of charge
$17.00
1,159.26%
register free of charge
$14.00
937.04%
register free of charge
|
|
A rating was issued by 5 analysts: 4 Analysts recommend Reviva Pharmaceuticals Holdings Inc. to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Reviva Pharmaceuticals Holdings Inc. stock has an average upside potential 2025 of
1,025.93%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.65 | -0.87 |
32.00% | 47.27% | |
P/E | negative |
5 Analysts have issued a Reviva Pharmaceuticals Holdings Inc. forecast for earnings per share. The average Reviva Pharmaceuticals Holdings Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Reviva Pharmaceuticals Holdings Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.